AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 193 filers reported holding AIMMUNE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $7,744,000 | +99.3% | 224,805 | -3.3% | 0.00% | +100.0% |
Q2 2020 | $3,885,000 | +16.4% | 232,469 | +0.5% | 0.00% | 0.0% |
Q1 2020 | $3,338,000 | -85.0% | 231,420 | -65.1% | 0.00% | -83.3% |
Q4 2019 | $22,196,000 | +7.7% | 663,159 | -32.6% | 0.01% | 0.0% |
Q3 2019 | $20,600,000 | +177.2% | 983,754 | +175.6% | 0.01% | +200.0% |
Q2 2019 | $7,431,000 | +61.9% | 356,967 | +73.9% | 0.00% | +100.0% |
Q1 2019 | $4,590,000 | -65.3% | 205,328 | -62.9% | 0.00% | -75.0% |
Q4 2018 | $13,233,000 | +183.6% | 553,206 | +223.4% | 0.00% | +300.0% |
Q3 2018 | $4,666,000 | +1.0% | 171,052 | -0.4% | 0.00% | 0.0% |
Q2 2018 | $4,619,000 | -7.9% | 171,766 | +9.1% | 0.00% | 0.0% |
Q1 2018 | $5,013,000 | -0.8% | 157,483 | +17.9% | 0.00% | 0.0% |
Q4 2017 | $5,052,000 | +51.4% | 133,585 | -0.8% | 0.00% | 0.0% |
Q3 2017 | $3,337,000 | +23.6% | 134,614 | +2.5% | 0.00% | 0.0% |
Q2 2017 | $2,700,000 | +10.6% | 131,353 | +16.9% | 0.00% | 0.0% |
Q1 2017 | $2,441,000 | -12.4% | 112,337 | -17.5% | 0.00% | 0.0% |
Q4 2016 | $2,786,000 | +104.9% | 136,238 | +50.3% | 0.00% | – |
Q3 2016 | $1,360,000 | +52.0% | 90,663 | +9.7% | 0.00% | – |
Q2 2016 | $895,000 | +28.4% | 82,661 | +60.8% | 0.00% | – |
Q1 2016 | $697,000 | -15.2% | 51,416 | +15.4% | 0.00% | – |
Q4 2015 | $822,000 | +23.2% | 44,549 | +69.1% | 0.00% | – |
Q3 2015 | $667,000 | – | 26,343 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|